Merck Is Second Big Pharma To Join Optum Labs Research Collaborative
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck follows Pfizer in signing on to the research collaborative affiliated with insurer UnitedHealth. Research underway or already completed through the collaborative includes a comparison of diabetes drugs and an effort to replicate results of the NIH-sponsored ACCORD trial on cholesterol treatments.